After being fitted with a pacemaker for heart failure, Pat Wilkinson was told bluntly that she had a 50-50 chance of being alive in five years’ time.
‘I was told before the operation that the battery should last at least ten years, and the doctors made it clear they thought it would last longer than me,’ recalls Pat, now 80, from Winchcombe in Gloucestershire.
Widecells Group (LON:WDC) are leading a transformation in cord blood banking and stem cell treatment; making cord blood banking more accessible through insurance coverage, and increasing the availability of cord blood for transplants.